Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | %Female (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 13.345 Q1 | 254 | 29 | 68 | 7430 | 2163 | 67 | 27.67 | 256.21 | 22.14 | |
2 | Annual Review of Pharmacology and Toxicology | journal | 11.847 Q1 | 224 | 25 | 83 | 3063 | 1871 | 82 | 23.20 | 122.52 | 29.85 | |
3 | Pharmacology and Therapeutics | journal | 3.119 Q1 | 233 | 62 | 196 | 12447 | 1525 | 193 | 7.67 | 200.76 | 26.54 | |
4 | Cell Chemical Biology | journal | 3.110 Q1 | 206 | 165 | 391 | 5931 | 2208 | 369 | 5.45 | 35.95 | 29.72 | |
5 | Molecular Pharmacology | journal | 2.724 Q1 | 210 | 339 | 1029 | 12981 | 6014 | 1027 | 5.73 | 38.29 | 36.05 | |
6 | Medicinal Research Reviews | journal | 2.603 Q1 | 150 | 29 | 76 | 4077 | 597 | 76 | 8.13 | 140.59 | 46.77 | |
7 | Antimicrobial Agents and Chemotherapy | journal | 2.208 Q1 | 289 | 710 | 2041 | 19690 | 10076 | 1960 | 4.81 | 27.73 | 37.38 | |
8 | Pain | journal | 2.195 Q1 | 296 | 307 | 738 | 12357 | 3877 | 673 | 4.83 | 40.25 | 35.96 | |
9 | Molecular Therapy | journal | 2.122 Q1 | 209 | 248 | 611 | 7857 | 3181 | 520 | 4.97 | 31.68 | 30.24 | |
10 | Journal of Pharmacology and Experimental Therapeutics | journal | 1.682 Q1 | 244 | 610 | 1808 | 22972 | 8365 | 1807 | 4.63 | 37.66 | 31.45 | |
11 | Drug Metabolism and Disposition | journal | 1.511 Q1 | 194 | 212 | 706 | 6722 | 2777 | 699 | 3.95 | 31.71 | 30.31 | |
12 | Drug Resistance Updates | journal | 1.502 Q1 | 132 | 33 | 114 | 2929 | 467 | 106 | 5.09 | 88.76 | 31.08 | |
13 | British Journal of Pharmacology | journal | 1.474 Q1 | 244 | 533 | 1864 | 21798 | 6793 | 1844 | 3.54 | 40.90 | 35.37 | |
14 | Biochemical Pharmacology | journal | 1.427 Q1 | 220 | 481 | 1210 | 20367 | 4297 | 1182 | 3.02 | 42.34 | 35.91 | |
15 | Bioconjugate Chemistry | journal | 1.390 Q1 | 192 | 168 | 430 | 5729 | 1639 | 427 | 3.78 | 34.10 | 27.56 | |
16 | Cancer Biology and Therapy | journal | 1.343 Q1 | 130 | 164 | 136 | 7816 | 243 | 94 | 1.79 | 47.66 | 32.68 | |
17 | Microbial Drug Resistance | journal | 1.303 Q1 | 78 | 60 | 138 | 1535 | 389 | 138 | 2.63 | 25.58 | 50.47 | |
18 | Prostaglandins and Other Lipid Mediators | journal | 1.302 Q1 | 86 | 41 | 187 | 2066 | 497 | 183 | 2.81 | 50.39 | 24.11 | |
19 | Pharmaceutical Research | journal | 1.170 Q1 | 229 | 275 | 762 | 7452 | 2232 | 752 | 2.70 | 27.10 | 29.79 | |
20 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.164 Q1 | 82 | 13 | 45 | 1928 | 159 | 44 | 3.52 | 148.31 | 20.00 | |
21 | Toxicology and Applied Pharmacology | journal | 1.144 Q1 | 189 | 207 | 638 | 9431 | 2069 | 623 | 3.10 | 45.56 | 36.14 | |
22 | Journal of Natural Products | journal | 1.123 Q1 | 161 | 370 | 1258 | 7497 | 2669 | 1254 | 2.08 | 20.26 | 30.27 | |
23 | Journal of Immunotherapy | journal | 1.112 Q1 | 106 | 39 | 119 | 1227 | 410 | 106 | 4.20 | 31.46 | 34.40 | |
24 | Advances in Pharmacology | journal | 1.111 Q1 | 86 | 0 | 29 | 0 | 84 | 27 | 0.00 | 0.00 | 0.00 | |
25 | Clinical Pharmacology and Therapeutics | journal | 1.104 Q1 | 209 | 140 | 807 | 3952 | 2466 | 744 | 2.42 | 28.23 | 31.46 | |
26 | Behavioural Pharmacology | journal | 1.090 Q1 | 87 | 71 | 202 | 3022 | 459 | 189 | 1.99 | 42.56 | 42.66 | |
27 | Clinical Therapeutics | journal | 1.080 Q1 | 150 | 219 | 496 | 8226 | 1668 | 408 | 2.95 | 37.56 | 26.78 | |
28 | Pharmacology Biochemistry and Behavior | journal | 1.072 Q1 | 148 | 259 | 913 | 11935 | 2198 | 907 | 2.43 | 46.08 | 38.01 | |
29 | Experimental and Clinical Psychopharmacology | journal | 0.973 Q1 | 101 | 34 | 177 | 1404 | 305 | 176 | 1.39 | 41.29 | 33.04 | |
30 | Anti-Cancer Drug Design | journal | 0.917 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
31 | Steroids | journal | 0.906 Q1 | 114 | 134 | 351 | 5085 | 975 | 348 | 2.46 | 37.95 | 37.18 | |
32 | Journal of Cardiovascular Pharmacology | journal | 0.812 Q1 | 109 | 280 | 865 | 8842 | 1764 | 856 | 2.10 | 31.58 | 22.17 | |
33 | Journal of Biomolecular Screening | journal | 0.799 Q2 | 86 | 68 | 147 | 1404 | 373 | 139 | 2.47 | 20.65 | 35.71 | |
34 | Chirality | journal | 0.784 Q2 | 83 | 135 | 357 | 3989 | 616 | 352 | 1.63 | 29.55 | 23.11 | |
35 | Bulletin of Mathematical Biology | journal | 0.771 Q2 | 97 | 52 | 144 | 1790 | 231 | 143 | 1.56 | 34.42 | 23.85 | |
36 | Clinical Neuropharmacology | journal | 0.755 Q2 | 85 | 66 | 185 | 1726 | 470 | 175 | 2.42 | 26.15 | 29.77 | |
37 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.734 Q2 | 68 | 95 | 189 | 2887 | 371 | 172 | 1.93 | 30.39 | 27.60 | |
38 | Therapeutic Drug Monitoring | journal | 0.717 Q2 | 102 | 109 | 357 | 2652 | 923 | 343 | 2.63 | 24.33 | 30.69 | |
39 | Journal of Clinical Pharmacology | journal | 0.707 Q2 | 130 | 138 | 498 | 4346 | 1183 | 487 | 2.26 | 31.49 | 30.64 | |
40 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.697 Q2 | 150 | 148 | 392 | 8355 | 778 | 388 | 2.13 | 56.45 | 35.62 | |
41 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.674 Q2 | 70 | 21 | 54 | 473 | 80 | 51 | 1.48 | 22.52 | 23.08 | |
42 | CNS Drug Reviews | journal | 0.648 Q2 | 64 | 22 | 72 | 1957 | 148 | 72 | 2.65 | 88.95 | 32.20 | |
43 | Anti-Cancer Drugs | journal | 0.642 Q2 | 102 | 131 | 391 | 4304 | 816 | 389 | 2.19 | 32.85 | 29.58 | |
44 | Journal of AOAC International | journal | 0.634 Q2 | 100 | 168 | 642 | 2909 | 825 | 640 | 1.18 | 17.32 | 40.21 | |
45 | Vascular Pharmacology | journal | 0.567 Q2 | 108 | 34 | 184 | 1129 | 248 | 178 | 1.20 | 33.21 | 40.54 | |
46 | Journal of the American Pharmacists Association : JAPhA | journal | 0.544 Q2 | 73 | 149 | 438 | 1859 | 529 | 415 | 1.06 | 12.48 | 40.63 | |
47 | American Journal of Therapeutics | journal | 0.528 Q2 | 69 | 84 | 188 | 1233 | 365 | 163 | 2.02 | 14.68 | 26.55 | |
48 | Pharmacological Research | journal | 0.528 Q2 | 169 | 163 | 488 | 6120 | 791 | 487 | 1.57 | 37.55 | 35.94 | |
49 | Drug Development and Industrial Pharmacy | journal | 0.485 Q2 | 100 | 115 | 435 | 2603 | 404 | 432 | 0.93 | 22.63 | 27.80 | |
50 | Cardiovascular Drug Reviews | journal | 0.478 Q2 | 54 | 24 | 76 | 1324 | 143 | 76 | 2.52 | 55.17 | 28.30 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®